Equinox (Therapeutic Devices) Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 12

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $16.5M

  • Investors
  • 5

Equinox (Therapeutic Devices) General Information

Description

Developer of glaucoma treatment technology designed to treat diseases of the optic nerve. The company's technology uses an adjustable, non-surgical, non-pharmacological system that utilizes the natural laws of physics to balance pressures in and around their eye, enabling doctors to understand glaucoma based on a deep exploration into the physics of the eye pressure.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Primary Office
  • 2424 South East Bristol Street
  • Suite 250
  • Newport Beach, CA 92660
  • United States
+1 (949) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Equinox (Therapeutic Devices) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 05-Sep-2019 $16.5M 000.00 Completed Generating Revenue
4. Early Stage VC (Series B) 03-Mar-2018 0000 0000 Completed Generating Revenue
3. Seed Round 19-Dec-2017 00.000 Completed Generating Revenue
2. Grant 01-Mar-2015 Completed Generating Revenue
1. Angel (individual) Completed Startup
To view Equinox (Therapeutic Devices)’s complete valuation and funding history, request access »

Equinox (Therapeutic Devices) Patents

Equinox (Therapeutic Devices) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210220210-A1 Apparatus and methods to treat headaches Pending 10-Oct-2018 000000000
CA-3115926-A1 Apparatus and methods to treat headaches Pending 10-Oct-2018 00000000
EP-3833239-A1 Apparatus and methods to adjust ocular blood flow Pending 09-Aug-2018 00000000000
CA-3109225-A1 Apparatus and methods to adjust ocular blood flow Pending 09-Aug-2018 00000000000
US-20210153741-A1 Apparatus and methods to adjust ocular blood flow Pending 09-Aug-2018 A61F9/00781
To view Equinox (Therapeutic Devices)’s complete patent history, request access »

Equinox (Therapeutic Devices) Executive Team (7)

Name Title Board Seat Contact Info
Matthew Larson Chief Operating Officer & Global President
Gary Berman President, US
Paul Yoo Chief Scientific Officer
George Tsai Senior Advisor
Vanessa Tasso Vice President, Clinical & Regulatory
You’re viewing 5 of 7 executive team members. Get the full list »

Equinox (Therapeutic Devices) Board Members (8)

Name Representing Role Since
Alison Bauerlein Self Board Member 000 0000
J. Corley Self Board Member 000 0000
Jeffry Weinhuff Visionary Venture Fund Board Member 000 0000
Richard Lindstrom MD Self Board Member 000 0000
Stuart Raetzman Self Executive Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Equinox (Therapeutic Devices) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Equinox (Therapeutic Devices) Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
South Dakota Equity Partners Growth/Expansion Minority 000 0000 000000 0
Flying L Partners Venture Capital Minority 000 0000 000000 0
Visionary Venture Fund Venture Capital Minority 000 0000 000000 0
Bluestem Capital Company PE/Buyout Minority 000 0000 000000 0
National Space Biology Research Institute Corporation 000 0000 000000 0
To view Equinox (Therapeutic Devices)’s complete investors history, request access »